Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
February 23, 2016
Pediatric familial neuromyelitis optica in two sisters with long term follow-up
Miguel Chuquilin, Naresh Mullaguri, Brian Weinshenker
Neurologic Clinics
|
January 31, 2012
Acute demyelinating disorders: emergencies and management
Reem F Bunyan, Junger Tang, Brian Weinshenker
Neurology
|
November 24, 2004
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study
Hillel Panitch, Aaron Miller, Donald Paty, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 13, 2020
Challenges in multiple sclerosis diagnosis: Misunderstanding and misapplication of the McDonald criteria
Andrew J Solomon, Roman Pettigrew, Robert T Naismith, et al.
Multiple Sclerosis and Related Disorders
|
October 7, 2019
Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from Serbia
Jelena Drulovic, Vanja Martinovic, Irena Dujmovic Basuroski, et al.
Journal of the Neurological Sciences
|
September 20, 2005
Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial
Hillel Panitch, Douglas Goodin, Gordon Francis, et al.
Mayo Clinic Proceedings
|
December 11, 2021
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis
Ruba S Saadeh, Sandra C Bryant, Andrew McKeon, et al.
Multiple Sclerosis and Related Disorders
|
August 25, 2022
Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar
Takashi Yamamura, Brian Weinshenker, Michael R Yeaman, et al.
Lancet (London, England)
|
August 16, 2005
Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange
Mark Keegan, Fatima König, Robyn McClelland, et al.
Brain : a Journal of Neurology
|
June 22, 2002
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Claudia F Lucchinetti, Raul N Mandler, Dorian McGavern, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
February 23, 2016
Pediatric familial neuromyelitis optica in two sisters with long term follow-up
Miguel Chuquilin, Naresh Mullaguri, Brian Weinshenker
Neurologic Clinics
|
January 31, 2012
Acute demyelinating disorders: emergencies and management
Reem F Bunyan, Junger Tang, Brian Weinshenker
Neurology
|
November 24, 2004
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study
Hillel Panitch, Aaron Miller, Donald Paty, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 13, 2020
Challenges in multiple sclerosis diagnosis: Misunderstanding and misapplication of the McDonald criteria
Andrew J Solomon, Roman Pettigrew, Robert T Naismith, et al.
Multiple Sclerosis and Related Disorders
|
October 7, 2019
Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from Serbia
Jelena Drulovic, Vanja Martinovic, Irena Dujmovic Basuroski, et al.
Journal of the Neurological Sciences
|
September 20, 2005
Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial
Hillel Panitch, Douglas Goodin, Gordon Francis, et al.
Mayo Clinic Proceedings
|
December 11, 2021
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis
Ruba S Saadeh, Sandra C Bryant, Andrew McKeon, et al.
Multiple Sclerosis and Related Disorders
|
August 25, 2022
Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar
Takashi Yamamura, Brian Weinshenker, Michael R Yeaman, et al.
Lancet (London, England)
|
August 16, 2005
Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange
Mark Keegan, Fatima König, Robyn McClelland, et al.
Brain : a Journal of Neurology
|
June 22, 2002
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Claudia F Lucchinetti, Raul N Mandler, Dorian McGavern, et al.
Page
of 3